Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
francesca.megiorni@uniroma1.it
Francesca Megiorni
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
francesca.megiorni@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2020
Epigenetics in rhabdomyosarcoma: cues to new biomarkers and targeted therapies
EBIOMEDICINE
2020
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells
CANCER LETTERS
2020
Tlr4 t399i polymorphism and endometriosis in a cohort of italian women
DIAGNOSTICS
2020
Differential DNA Methylation Encodes Proliferation and Senescence Programs in Human Adipose-Derived Mesenchymal Stem Cells
FRONTIERS IN GENETICS
2020
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization
JOURNAL OF BIOMEDICAL SCIENCE
2020
Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma
ONCOGENE
2019
Notch3 targeting. A novel weapon against ovarian cancer stem cells
STEM CELLS INTERNATIONAL
2019
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
2019
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation
CANCER LETTERS
2019
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2019
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2019
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study
FRONTIERS IN ENDOCRINOLOGY
2019
Testosterone-mediates activation of androgenic signaling sustains in vitro the transformed and radioresistant phenotype of rhabdomysarcoma cell lines
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2018
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2018
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2018
Synergistic effects of PARP inhibitors and ionizing radiation on growth and survival of rhabdomyosarcoma cells
ANNALS OF ONCOLOGY
2018
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
CANCER LETTERS
2017
A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma
ONCOLOGY REPORTS
2017
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
JOURNAL OF HEMATOLOGY & ONCOLOGY
2017
« prima
< precedente
1
2
3
seguente ›
ultima »
Progetti di Ricerca
Epigenetic dynamics for enhancing therapeutic efficacy and immunomodulatory activity of adipose-derived stem cells in regenerative medicine: a biological, molecular and computational approach.
Non-coding RNAs and epigenetic drivers in ovarian cancer development and drug resistance: cues to new biomarkers and efficient targeted therapies.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma